omalizumab in the United States
14 medicine records from 5 holders carry this name in the official sources. Collected on November 11, 2026.
Medicines
| Name | Holder | Code |
|---|---|---|
| omalizumab LIQUID | Novartis Pharmaceuticals Corporation |
Product NDC
0078-1336Package NDC
0078-1336-09
|
| omalizumab INJECTION, SOLUTION | Novartis Pharma Stein AG |
Product NDC
17088-0268Package NDC
17088-0268-1
|
| omalizumab INJECTION, SOLUTION | Novartis Pharma Stein AG |
Product NDC
17088-0275Package NDC
17088-0275-1
|
| omalizumab INJECTION, SOLUTION | Novartis Pharma Stein AG |
Product NDC
17088-0282Package NDC
17088-0282-1
|
| omalizumab INJECTION, SOLUTION | Novartis Pharma Stein AG |
Product NDC
17088-0386Package NDC
17088-0386-1
|
| Omalizumab LIQUID | Genentech, Inc. |
Product NDC
50242-408Package NDC
50242-408-01
|
| omalizumab LIQUID | NOVARTIS PHARMA SAS |
Product NDC
66447-0104Package NDC
66447-0104-9
|
| OMLYCLO INJECTION | CELLTRION USA, Inc. |
Product NDC
72606-035Package NDC
72606-035-01
|
| OMLYCLO INJECTION | CELLTRION USA, Inc. |
Product NDC
72606-036Package NDC
72606-036-01
|
| OMLYCLO INJECTION | CELLTRION USA, Inc. |
Product NDC
72606-054Package NDC
72606-054-01
|
| XOLAIR INJECTION, SOLUTION | Genentech, Inc. |
Product NDC
50242-040Package NDC
50242-040-62
|
| Xolair INJECTION, SOLUTION | Genentech, Inc. |
Product NDC
50242-227Package NDC
50242-227-01
|
| Xolair PFS INJECTION, SOLUTION | Genentech, Inc. |
Product NDC
50242-214Package NDC
50242-214-03
|
| Xolair PFS INJECTION, SOLUTION | Genentech, Inc. |
Product NDC
50242-215Package NDC
50242-215-03
|
Need this list in your own system?
Every record on this page is available through the API, with its source, licence and retrieval date.